Units to Merge in Unusual Collaboration as Pharmaceutical Industry Contends With Slowing Growth.
GlaxoSmithKline PLC and Pfizer Inc. are combining their HIV-drug businesses in a rare collaboration as the pharmaceutical rivals attempt to breathe life into a challenging product segment.
Read More...
